SZ137 (Amoxicillin and clavulanate potassium extended release 1000 mg / 62.5 mg)
Pill imprint SZ137 has been identified as Amoxicillin and clavulanate potassium extended release 1000 mg / 62.5 mg.
Amoxicillin/clavulanate is used in the treatment of bacterial infection; skin or soft tissue infection; sinusitis; urinary tract infection; bronchitis (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 1000 mg / 62.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 1000 mg / 62.5 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Beta-lactamase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid monohydrate
sodium starch glycolate type A potato
More about amoxicillin/clavulanate
- Amoxicillin and Clavulanate
- Amoxicillin/clavulanate chewable tablets
- Amoxicillin/clavulanate extended-release tablets
- Amoxicillin/clavulanate suspension
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.